BioCryst Pharmaceuticals, Inc. Long-Term Investments

Long-Term Investments of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-Term Investments growth rates and interactive chart. An accounting item that represents the company's investments, including stocks, bonds, real estate, and cash. Long-term investments are assets that a company intends to hold for more than a year. The long-term investment account differs largely from the short-term investment account in that short-term investments will most likely be sold, whereas the long-term investments will not be sold for years and, in some cases, may never be sold.


Highlights and Quick Summary

  • Long-Term Investments for the quarter ending September 30, 2022 was $34.3 Million (a 402.74% increase compared to previous quarter)
  • Year-over-year quarterly Long-Term Investments increased by 4533.2%
  • Annual Long-Term Investments for 2021 was $6.83 Million (a -69.48% decrease from previous year)
  • Annual Long-Term Investments for 2018 was $22.4 Million (a -45.81% decrease from previous year)
  • Annual Long-Term Investments for 2017 was $41.3 Million (a 362.64% increase from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-Term Investments of BioCryst Pharmaceuticals, Inc.

Most recent Long-Term Investmentsof BCRX including historical data for past 10 years.

Interactive Chart of Long-Term Investments of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Long-Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $34.33
2021 $6.83 $6.83
2020 $3.0
2019 $0.74 $11.66
2018 $22.38 $29.16 $33.74 $41.6 $22.38
2017 $41.3 $4.54 $9.6 $3.8 $41.3
2016 $8.93 $14.37 $24.15 $41.13 $8.93
2015 $47.68 $47.79 $36.06 $41.12 $47.68
2014 $41.12 $0.3 $0.6 $2.68 $41.12
2013 $2.58 $0.68 $2.58
2012 $1.15 $2.51 $16.35 $13.07 $1.15

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology